Company: ARTL
Filing Date: 2025-11-17
Form Type: S-1
Source: 0001640334-25-002154
Chunk: 28

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-17
Form: S-1
Chunk 28
---
400 shares held directly by Peter O’Brien and (v) 581 shares of Common Stock issuable pursuant to options held directly by Peter O’Brien exercisable within 60 days of November 10, 2025. The principal address of Peter O’Brien is 1 Albert Tce, Mesrh Rd, Bray, Co Wicklow Ireland.                                                                                                                                                   |
| (8)  | Consists of (i) 12,349 shares of Common Stock issuable upon conversion of the Notes, (ii) 13,694 shares of Common Stock issuable upon exercise of the $6.24 Warrants and (iii) 25,134 shares of Common Stock issuable upon exercise of the $3.40 Warrants. The principal address of David Waldman is 995 Orion Court, Merrick, NY 11566.                                                                                                                                                                                                                                                                                                                                                             |
| (9)  | Consists of (i) 8,644 shares of Common Stock issuable upon conversion of the Notes, (ii) 9,586 shares of Common Stock issuable upon exercise of the $6.24 Warrants, (iii) 17,592 shares of Common Stock issuable upon exercise of the $3.40 Warrants, (iv) 3,008 shares of Common Stock held directly by Gregory D. Gorgas, (v) 400 shares of Common Stock held indirectly by Gorgas Family Trust and (vi) 49,328 shares of Common Stock issuable pursuant to options held directly by Gregory D. Gorgas exercisable within 60 days of November 10, 2025. The principal address of Gregory D. Gorgas is c/o Artelo Biosciences, Inc., 505 Lomas Santa Fe, Suite 160, Solana Beach, California 92075. |
| (10) | Consists of (i) 6,174 shares of Common Stock issuable upon conversion of the Notes, (ii) 6,846 shares of Common Stock issuable upon exercise of the $6.24 Warrants, (iii) 12,566 shares of Common Stock issuable upon exercise of the $3.40 Warrants and (iv) 2,278 shares of Common Stock issuable pursuant to options held directly by Tamara A. Favorito exercisable within 60 days of November 10, 2025. The principal address of Tamara A. Favorito is c/o Artelo Biosciences, Inc., 505 Lomas Santa